XML 124 R108.htm IDEA: XBRL DOCUMENT v3.21.2

License Agreements (Details) - USD ($) $ in Millions		1 Months Ended				12 Months Ended
	Apr. 12, 2021	Apr. 30, 2020	Oct. 31, 2018	Oct. 31, 2017	Feb. 29, 2016	Jun. 30, 2021
License Agreement 2014 | Maximum | Neos Therapeutics, Inc.
Lump sum non-refundable license fee					$ 1.0
License Agreement 2017 | Maximum | Neos Therapeutics, Inc.
Lump sum non-refundable license fee				$ 1.0
License Agreement 2014 and 2017 | Neos Therapeutics, Inc.
License agreement term		10 years
License fee		$ 0.3
Patent prosecution fees		0.1
NeuRx License, Royalty Bearing License Agreement
Payments for license agreement			$ 0.2			$ 0.2
Payments for contingent consideration on license agreement		$ 0.3
In-process R&D | Rumpus
Contingent consideration	$ 67.5
Cash transferred	1.5
Payment of aggregated fees	0.6
In-process R&D | Rumpus | Maximum
Contingent consideration	$ 67.5

X

- Definition

Amount of consideration transferred in asset acquisition. Includes, but is not limited to, cash, liability incurred by acquirer, and equity interest issued by acquirer.

+ References

No definition available.

+ Details

Name:	aytu_AssetAcquisitionConsiderationTransferred
Namespace Prefix:	aytu_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Definition

Amount of consideration transferred for transaction cost incurred in asset acquisition.

+ References

No definition available.

+ Details

Name:	aytu_AssetAcquisitionConsiderationTransferredForTransactionCost
Namespace Prefix:	aytu_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Definition

Represents the information pertaining to for contingent consideration arrangements recognized in connection with an asset purchase, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.

+ References

No definition available.

+ Details

Name:	aytu_AssetPurchaseContingentConsiderationArrangementsRangeOfOutcomesValueHigh
Namespace Prefix:	aytu_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

X

- Definition

Period of license agreement in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

+ References

No definition available.

+ Details

Name:	aytu_LicenseAgreementTerm
Namespace Prefix:	aytu_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Represent the information pertaining to license fee.

+ References

No definition available.

+ Details

Name:	aytu_LicenseFee
Namespace Prefix:	aytu_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Definition

Represents lump sum non-refundable license fee.

+ References

No definition available.

+ Details

Name:	aytu_LumpSumNonrefundableLicenseFee
Namespace Prefix:	aytu_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Definition

Represents the information pertaining to patent prosecution fees.

+ References

No definition available.

+ Details

Name:	aytu_PatentProsecutionFees
Namespace Prefix:	aytu_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Definition

The cash outflow associated with the contingent consideration on the license agreement.

+ References

No definition available.

+ Details

Name:	aytu_PaymentsForContingentConsiderationOnLicenseAgreement
Namespace Prefix:	aytu_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Definition

The amount of cash paid for the license agreement.

+ References

No definition available.

+ Details

Name:	aytu_PaymentsForLicenseAgreement
Namespace Prefix:	aytu_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Details

Name:	us-gaap_TypeOfArrangementAxis=aytu_LicenseAgreement2014Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_RangeAxis=srt_MaximumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	dei_LegalEntityAxis=aytu_NeosTherapeuticsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_TypeOfArrangementAxis=aytu_LicenseAgreement2017Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_TypeOfArrangementAxis=aytu_LicenseAgreement2014And2017Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=aytu_NeuRxLicenseRoyaltyBearingLicenseAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	aytu_AssetAcquisitionAxis=aytu_RumpusMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: